ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1095

Engagement with the RISE Registry Clinician Dashboard Is Associated with Higher Performance on Rheumatology Quality Measures

Emma Kersey1, Jing Li1, Julia Kay1, Julia Adler-Milstein1, Jinoos Yazdany2 and Gabriela Schmajuk3, 1University of California San Francisco, San Francisco, CA, 2University of California, General Department of Medicine, Division of Rheumatology, San Francisco, CA, 3UCSF / SFVA, San Francisco, CA

Meeting: ACR Convergence 2023

Keywords: Health Services Research, informatics, quality of care, registry

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Monday, November 13, 2023

Title: (1082–1099) Measures & Measurement of Healthcare Quality Poster I

Session Type: Poster Session B

Session Time: 9:00AM-11:00AM

Background/Purpose: The American College of Rheumatology’s Rheumatology Informatics System for Effectiveness (RISE) EHR-based registry facilitates quality measure calculation and reporting for rheumatology practices in national pay-for-performance programs. Participating practices can leverage RISE’s web-based clinician dashboard to monitor performance on quality measures, benchmark performance against registry means, and explore patient-level data to identify gaps in care. Despite substantial investment in these dashboards, the extent to which they help improve performance on quality measures remains unclear. We investigated the relationship between practice engagement with the RISE web-based dashboard and performance on rheumatology-specific measures in 2021.

Methods: Eligible practices were categorized into 3 engagement groups based on practice personnel’s dashboard interactions (number of sessions and actions performed, such as drilldowns and exports) during the study period: no engagement (0 sessions), some engagement (≤ median actions), high engagement ( > median actions) (Table). Practice performance was assessed on both individual and composite measures, utilizing all available rheumatology-specific measures (range 1 to 8) per practice that had ≥20 eligible patients. The composite measure incorporated all rheumatology-specific measures per practice and was denominator-weighted, i.e., based on the number of patients included in each individual measure denominator. Individual measure performance analysis was restricted to measures with data from ≥5 practices per engagement group. Linear regression models were used to calculate predictive margins and 95% confidence intervals for quality performance for each engagement group. Differences in performance across engagement groups were assessed via pairwise comparisons; linear trends were evaluated using orthogonal polynomial contrasts (Figure).

Results: Most of the 204 included practices were single-specialty (59.8%) or solo practices (29.4%), with a median of 2 providers and 4970 patients (Table). Among these practices, 11% had no dashboard engagement, 76% had some engagement, and 12% were highly engaged. Performance on individual rheumatology-specific measures ranged from 28%-72% (median (IQR) 60% (47-66%)). The majority of practices’ (75%) composite scores included ≥3 out of 8 possible rheumatology-specific measures with a median (IQR) performance of 65% (40-79%). We observed a pattern of higher measure performance with more dashboard engagement: 3 out of 5 individual rheumatology-specific measures and the composite measure exhibited a significant linear trend at the 5% level (Figure).

Conclusion: This cross-sectional analysis revealed a dose-response between degree of dashboard engagement and practice-level quality performance: RISE practices with higher levels of dashboard engagement exhibited better quality performance. Further investigation is needed to determine whether more dashboard engagement yields meaningful quality improvement over time, and whether performance is determined by engagement or vice versa.

Supporting image 1

Supporting image 2


Disclosures: E. Kersey: None; J. Li: None; J. Kay: Pfizer, 12, Own Stock; J. Adler-Milstein: None; J. Yazdany: AstraZeneca, 2, 5, Aurinia, 5, Gilead, 5, Pfizer, 2; G. Schmajuk: None.

To cite this abstract in AMA style:

Kersey E, Li J, Kay J, Adler-Milstein J, Yazdany J, Schmajuk G. Engagement with the RISE Registry Clinician Dashboard Is Associated with Higher Performance on Rheumatology Quality Measures [abstract]. Arthritis Rheumatol. 2023; 75 (suppl 9). https://acrabstracts.org/abstract/engagement-with-the-rise-registry-clinician-dashboard-is-associated-with-higher-performance-on-rheumatology-quality-measures/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2023

ACR Meeting Abstracts - https://acrabstracts.org/abstract/engagement-with-the-rise-registry-clinician-dashboard-is-associated-with-higher-performance-on-rheumatology-quality-measures/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology